Alleged Stark violations, kickbacks to cost hospital $50M

A 223-bed acute care institution with a medical staff of nearly 300 physicians has agreed to pay $50 million over allegations it deliberately submitted ineligible claims to Medicare and profited handsomely by these actions.  

As reported by the U.S. Department of Justice Sep. 9, the alleged deeds were done at Wheeling Hospital in West Virginia.

Justice specifically accused the hospital and a management consultancy of systematically violating the Physician Self-Referral Law, aka the Stark Law, as well as the Anti-Kickback Statute from 2007 to 2020.

Justice says the accused “knowingly and willfully” payed “improper compensation to referring physicians that was based on the volume or value of the physicians’ referrals or was above fair market value.”

The hospital made a profit of nearly $90 million within five years of contracting with the consultancy, which made millions of its own for services rendered to Wheeling Hospital, the Pittsburgh Post-Gazette is reporting.

This week’s settlement caps a whistleblower complaint filed in 2017 by a former Wheeling Hospital executive VP, Louis Longo.

Longo will receive $10 million from the payout, Justice says.

“Medicare and Medicaid beneficiaries trust that their healthcare providers will make decisions based on sound medical judgment,” Scott W. Brady, the U.S. Attorney for the Western District of Pennsylvania, says in prepared remarks. “Our office will take decisive action against any medical providers which betray that trust and make medical decisions based on their own financial interests. Our seniors deserve nothing less.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”